| Name | IWR-1-endo |
|---|---|
| Synonyms |
IWR-1-endo - IWR-1 | endo-IWR-1
IWR-1-endo, >= 4-[(1R,2S,6R,7S)-3,5-Dioxo-4-azatricyclo[5.2.1.0]dec-8-en-4-yl]-N-(8-quinolinyl)benzamide ENDO-IWR 1;IWR-1-ENDO;IWR1;IWR 1 4-((3,4R,7S,7aS)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)-N-(quinolin-8-yl)benzamide IWR-1-endo ,S7086 [(3*,4S*,7R*,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide rel-4-[(3,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide IWR-1-endo Wnt Antagonist I, IWR-1-endo IWR-1-endo //BP rel-4-[(3,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-Methano-2H-isoindol-2-yl]-N-8-quinolinylbenzaMide rel-4-((3,4S,7R,7aS)-1,3-Dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)-N-(quinolin-8-yl)benzamide IWR-1(IWR-1-endo) 4-[(1R,2S,6R,7S)-3,5-Dioxo-4-azatricyclo[5.2.1.0]dec-8-en-4-yl]-N-(quinolin-8-yl)benzamide IWR-1, 10 mM in DMSO Benzamide, 4-[(3,4S,7R,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinyl-, rel endo-IWR 1 4-(1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl)-N-8-quinolinyl-Benzamide (IWR-1) |
| Description | IWR-1 is a tankyrase inhibitor which inhibits Wnt/β-catenin signaling pathway. |
|---|---|
| Related Catalog | |
| Target |
IC50: 180 nM (Wnt) |
| In Vitro | Both IWR-1 and XAV939 act as reversible Wnt pathway inhibitors and exhibit similar pharmacological effects in vitro. IWR-1 exerts its effect via interaction with Axin, while XAV939 binds TNKS directly[1]. IWR-1 (10 μM) induces stabilization of β-catenin disruption complex. IWR-1 (10 μM) is added to the medium together with MIF, the size of cell colonies is extremely decreased, and that indicates the promoting effect of MIF on NSPC proliferation is inhibited by IWR-1 in any MIF concentration group. 2, 5 and 10 μM of IWR-1 significantly inhibits the proliferation of NSPC dose-dependently. IWR-1 inhibites the promoting effect of MIF on NSPC differentiation to neuron lineage[2]. IWR-1 treatment in the presence of maximal stimulatory dose of FSH (0.5 ng/mL) results in a dose dependent inhibition of the stimulatory effect of FSH with > 75% inhibition observed at the maximal inhibitory dose of IWR-1 (1 µM). IWR-1 treatment partially reverses the FSH-induced inhibition of granulosa cell CARTPT mRNA expression[3]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 643.9±55.0 °C at 760 mmHg |
| Molecular Formula | C25H19N3O3 |
| Molecular Weight | 409.437 |
| Flash Point | 343.2±31.5 °C |
| Exact Mass | 409.142639 |
| PSA | 79.37000 |
| LogP | 2.65 |
| Appearance | white to beige |
| Vapour Pressure | 0.0±1.9 mmHg at 25°C |
| Index of Refraction | 1.741 |
| Storage condition | Store at RT |
| Water Solubility | DMSO: soluble5mg/mL, clear |